CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Reconciliation of net income to cash provided by operating activities:
Net income	$ 32,494	$ 163,525
Add (deduct):
Depreciation and amortization	46,848	42,103
Adjustments for bad debt provisions	2,425	812
Net realized and unrealized losses	4,829	14,194
Amortization of net premium on debt securities investments	448	1,870
Payments for title losses (in excess of) less than provisions	(26,417)	10,950
Adjustments for insurance recoveries of title losses	0	220
Decrease in receivables – net	7,007	9,521
Increase in other assets – net	(9,581)	(4,343)
Decrease in accounts payable and other liabilities – net	(24,766)	(81,987)
Change in net deferred income taxes	(692)	25
Net income from equity method investments	(847)	(2,536)
Dividends received from equity method investments	1,121	3,135
Stock-based compensation expense	10,310	9,239
Other – net	399	312
Cash provided by operating activities	43,578	167,040
Investing activities:
Proceeds from sales of investments in securities	53,630	47,954
Proceeds from matured investments in debt securities	58,005	28,754
Purchases of investments in securities	(72,857)	(165,130)
Net purchases of short-term investments	(14,005)	(1,632)
Purchases of property and equipment, and real estate	(29,487)	(35,274)
Proceeds from sale of property and equipment and other assets	369	977
Cash paid for acquisition of businesses	(25,100)	(102,864)
Increase in notes receivable	(6,960)	(69)
Other – net	(348)	1,941
Cash used by investing activities	(36,753)	(225,343)
Financing activities:
Proceeds from notes payable	3,538	38,012
Payments on notes payable	(5,776)	(75,505)
Distributions to noncontrolling interests	(11,646)	(14,863)
Repurchases of Common Stock	(1,576)	(3,168)
Proceeds from stock option and employee stock purchase plan exercises	4,846	5,799
Cash dividends paid	(37,524)	(32,464)
Payment of contingent consideration related to acquisitions	(3,025)	(15,997)
Purchase of remaining interest in consolidated subsidiaries	0	(72)
Other - net	0	115
Cash used by financing activities	(51,163)	(98,143)
Effects of changes in foreign currency exchange rates	(1,044)	(8,540)
Change in cash and cash equivalents	(45,382)	(164,986)
Cash and cash equivalents at beginning of period	248,367	485,919
Cash and cash equivalents at end of period	$ 202,985	$ 320,933